Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Assets Average (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Assets Average for 4 consecutive years, with $510.8 million as the latest value for Q4 2025.

  • For Q4 2025, Assets Average fell 13.69% year-over-year to $510.8 million; the TTM value through Dec 2025 reached $510.8 million, down 13.69%, while the annual FY2025 figure was $545.3 million, 13.74% up from the prior year.
  • Assets Average was $510.8 million for Q4 2025 at Day One Biopharmaceuticals, down from $516.4 million in the prior quarter.
  • The five-year high for Assets Average was $591.8 million in Q4 2024, with the low at $335.9 million in Q2 2022.
  • Historically, Assets Average has averaged $437.7 million across 4 years, with a median of $395.1 million in 2023.
  • Biggest YoY gain for Assets Average was 58.98% in 2025; the steepest drop was 13.69% in 2025.
  • Over 4 years, Assets Average stood at $365.5 million in 2022, then grew by 8.11% to $395.1 million in 2023, then skyrocketed by 49.78% to $591.8 million in 2024, then decreased by 13.69% to $510.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $510.8 million in Q4 2025, $516.4 million in Q3 2025, and $526.7 million in Q2 2025.